The Efficacy and Safty of FMT in Patients With CID

NCT05917379 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-02-27

No results posted yet for this study

Summary

This clinical trial aims to learn about the efficacy of fecal microbiota transplantation in patients with chronic insomnia disorder. The main question\[s\] it aims to answer is:

• Effectiveness of the FMT oral capsule route for patients with chronic insomnia Participants in the intervention group will be given FMT by boral capsule pathway, and in the control group, they will be given the same appearance capsules containing starch.

Researchers will compare the sleep status(PSQI and PSG)of the patients in both groups.

Conditions

Interventions

BIOLOGICAL

fecal microbiota

FMT utilizes stool from a healthy donor and puts them into capsules after processing

OTHER

Placebo

Starch into the same outlook capsule with fecal microbiota

DIETARY_SUPPLEMENT

synbiotics

Lactobacillus Helveticas+ Bifidobacterial longum + inulin(3g/day)

Sponsors & Collaborators

  • Hefei Fourth People's Hospital/Anhui Mental Health Center

    collaborator UNKNOWN
  • The Second Hospital of Anhui Medical University

    collaborator OTHER
  • First Affiliated Hospital of Chongqing Medical University

    collaborator OTHER
  • Henan Provincial Mental Hospital/The Second Affiliated Hospital of Xinxiang Medical University

    collaborator UNKNOWN
  • The First Affiliated Hospital of Shanxi Medical University

    collaborator OTHER
  • Shandong First Medical University

    collaborator OTHER
  • Peking University Sixth Hospital

    lead OTHER

Principal Investigators

  • Lu · Peking University six hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-08
Primary Completion
2025-04-10
Completion
2025-07-24

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05917379 on ClinicalTrials.gov